Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus

被引:11
作者
Conley, Robert B. [1 ]
Dickson, Dane [2 ]
Zenklusen, Jean Claude [3 ]
Al Naber, Jennifer [1 ]
Messner, Donna A. [1 ]
Atasoy, Ajlan [4 ]
Chaihorsky, Lena [5 ]
Collyar, Deborah [6 ]
Compton, Carolyn [7 ]
Ferguson, Martin [3 ]
Khozin, Sean [8 ]
Klein, Roger D. [9 ]
Kotte, Sri [10 ]
Kurzrock, Razelle [11 ]
Lin, C. Jimmy
Liu, Frank [12 ]
Marino, Ingrid [13 ]
McDonough, Robert [14 ]
McNeal, Amy [15 ]
Miller, Vincent [13 ]
Schilsky, Richard L. [16 ]
Wang, Lisa I. [17 ]
机构
[1] Ctr Med Technol Policy, Baltimore, MD 21202 USA
[2] Mol Evidence Dev Consortium, Rexburg, ID 83440 USA
[3] Natl Canc Inst, Bethesda, MD 20892 USA
[4] European Org Res Treatment Canc, B-1200 Brussels, Belgium
[5] Qiagen, Waltham, MA 02451 USA
[6] Patient Advocates Res, Danville, CA 94526 USA
[7] Arizona State Univ, Mayo Clin, Phoenix, AZ 85257 USA
[8] US FDA, Silver Spring, MD 20993 USA
[9] Cleveland Clin, Beachwood, OH 44122 USA
[10] Natera, San Carlos, CA 94070 USA
[11] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[12] Merck Sharp & Dohme Ltd, North Wales, PA 19454 USA
[13] Fdn Med, Cambridge, MA 02141 USA
[14] Aetna, Hartford, CT 06156 USA
[15] Biocept, San Diego, CA 92121 USA
[16] Amer Soc Clin Oncol, Alexandria, VA 22314 USA
[17] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1016/j.cell.2017.10.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology.
引用
收藏
页码:982 / 986
页数:5
相关论文
共 5 条
[1]  
[Anonymous], 2013, INT CLASS DIS ONC IC
[2]  
National Human Genome Research Institute, 2000, INT HUM GEN SEQ CONS
[3]  
NIH, 2015, RAC ETHN CAT DEF NIH
[4]  
[Use of Biomarkers for Molecularly Targeted Therapies Medicine Committee on Policy Issues in the Clinical Development National Academies of Sciences Engineering], 2016, BIOM TESTS MOL TARG
[5]  
World Health Organisation, 1990, INT CLASS DIS 10